salmeterol xinafoate has been researched along with lactose in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (65.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartley, P; Islam, N; Larson, I; Stewart, P | 3 |
| Chow, AH; Shekunov, BY; Tong, HH; York, P | 1 |
| Adi, H; Chiou, H; Larson, I; Stewart, P; Traini, D; Young, P | 2 |
| Adi, H; Larson, I; Stewart, PJ | 1 |
| Dawson, ML; Ferrie, AR; Harris, H; Hooton, JC; Jones, MD; King, GS; Mathoulin, CA; Nichol, K; Price, R; Shur, J; Smith, TL | 1 |
| Marriott, C; Martin, GP; Murnane, D | 1 |
| Das, S; Larson, I; Stewart, P; Young, P | 2 |
| Handoko, A; Ian, L; Peter, SJ | 1 |
| Donovan, R; Elder, D; Freney, E; New, A; Prime, D; Zomer, S | 1 |
| Marriott, C; Martin, GP; Taki, M; Zeng, XM | 1 |
| de Boer, HA; Frijlink, HW; Grasmeijer, F; Hagedoorn, P | 1 |
| Depasquale, R; Lee, SL; Price, R; Saluja, B; Shur, J | 1 |
| Buttini, F; Forbes, B; Hammond, M; Hassoun, M; Ho, S; Muddle, J; Parry, M | 1 |
| Hoe, S; Lechuga-Ballesteros, D; Vehring, R; Wang, H; Williams, L | 1 |
| Choi, HG; Jin, SG; Kim, DW; Kim, JH; Kim, JO; Kim, KS; Oh, KT; Woo, JS; Yong, CS; Youn, YS | 1 |
| Chan, HK; Holl, MMB; Ke, WR; Khanal, D; Kim, J; Zhang, J | 1 |
20 other study(ies) available for salmeterol xinafoate and lactose
| Article | Year |
|---|---|
Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Capsules; Chromatography, High Pressure Liquid; Drug Carriers; Lactose; Models, Chemical; Particle Size; Regression Analysis; Salmeterol Xinafoate; Spectrophotometry, Ultraviolet | 2004 |
Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?
Topics: Administration, Inhalation; Albuterol; Drug Carriers; Lactose; Particle Size; Salmeterol Xinafoate | 2004 |
Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy.
Topics: Adhesiveness; Adrenergic beta-Agonists; Albuterol; Drug Carriers; Lactose; Microscopy, Atomic Force; Microscopy, Confocal; Salmeterol Xinafoate; Silicon Dioxide; Spectrometry, X-Ray Emission; Surface Properties | 2005 |
Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography.
Topics: Administration, Inhalation; Adsorption; Aerosols; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Chromatography, Gas; Forecasting; Humidity; Lactose; Powders; Salmeterol Xinafoate; Solubility | 2006 |
Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.
Topics: Administration, Inhalation; Aerosols; Albuterol; Drug Carriers; Lactose; Microscopy, Electron, Scanning; Particle Size; Powders; Salmeterol Xinafoate | 2006 |
Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
Topics: Administration, Inhalation; Albuterol; Carbohydrates; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Desiccation; Drug Carriers; Drug Compounding; Excipients; Glucose; Lactose; Lasers; Mannitol; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Reproducibility of Results; Salmeterol Xinafoate; Sorbitol; Surface Properties; Technology, Pharmaceutical; Water | 2007 |
Role of agglomeration in the dispersion of salmeterol xinafoate from mixtures for inhalation with differing drug to fine lactose ratios.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Chromatography, High Pressure Liquid; Drug Carriers; Lactose; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Salmeterol Xinafoate | 2008 |
An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
Topics: Adhesiveness; Administration, Inhalation; Albuterol; Androstadienes; Anti-Allergic Agents; Capsules; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Excipients; Fluticasone; Lactose; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Powders; Salmeterol Xinafoate; X-Ray Diffraction | 2008 |
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Fluticasone; Lactose; Nebulizers and Vaporizers; Particle Size; Polyethylene Glycols; Powders; Salmeterol Xinafoate | 2009 |
Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation.
Topics: Administration, Inhalation; Albuterol; Drug Carriers; Drug Stability; Drug Storage; Excipients; Humans; Humidity; Lactose; Particle Size; Powders; Salmeterol Xinafoate; Thermogravimetry | 2009 |
Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation.
Topics: Administration, Inhalation; Albuterol; Chemistry, Pharmaceutical; Excipients; Lactose; Microscopy, Electron, Scanning; Nebulizers and Vaporizers; Particle Size; Pharmaceutical Vehicles; Powders; Salmeterol Xinafoate; Sonication | 2009 |
Detection and assessment of co-association in inhalable drug particles using aerosol time-of-flight mass spectrometry.
Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Drug Combinations; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Lactose; Mass Spectrometry; Metered Dose Inhalers; Multivariate Analysis; Nebulizers and Vaporizers; Particle Size; Principal Component Analysis; Salmeterol Xinafoate | 2008 |
Agglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidity.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Drug Stability; Drug Storage; Excipients; Humidity; Lactose; Microscopy, Electron, Scanning; Particle Size; Powders; Pressure; Salmeterol Xinafoate | 2009 |
The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique.
Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Anti-Allergic Agents; Bronchodilator Agents; Chemical Fractionation; Crystallization; Drug Compounding; Excipients; Fluticasone; Humans; Lactose; Nebulizers and Vaporizers; Particle Size; Powders; Salmeterol Xinafoate | 2011 |
Mixing time effects on the dispersion performance of adhesive mixtures for inhalation.
Topics: Administration, Inhalation; Albuterol; Androstadienes; Chemistry, Pharmaceutical; Drug Carriers; Fluticasone; Lactose; Lasers; Microscopy, Electron, Scanning; Particle Size; Salmeterol Xinafoate; Solubility; Time Factors; X-Ray Diffraction | 2013 |
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.
Topics: Administration, Inhalation; Bronchodilator Agents; Chemistry, Pharmaceutical; Dry Powder Inhalers; Fluticasone; Lactose; Particle Size; Powders; Salmeterol Xinafoate; Surface Properties | 2015 |
Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
Topics: Administration, Inhalation; Aerosols; Chemistry, Pharmaceutical; Drug Carriers; Dry Powder Inhalers; Equipment Design; Lactose; Particle Size; Powders; Salmeterol Xinafoate | 2015 |
Quantitative Macro-Raman Spectroscopy on Microparticle-Based Pharmaceutical Dosage Forms.
Topics: Bronchodilator Agents; Fluticasone; Fluticasone-Salmeterol Drug Combination; Lactose; Particle Size; Powders; Salmeterol Xinafoate; Spectrum Analysis, Raman | 2015 |
Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
Topics: Administration, Inhalation; Aerosols; Capsules; Chemistry, Pharmaceutical; Dry Powder Inhalers; Fluticasone; Lactose; Particle Size; Powders; Salmeterol Xinafoate | 2018 |
Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.
Topics: Administration, Inhalation; Aerosols; Chemistry, Pharmaceutical; Dry Powder Inhalers; Excipients; Fluticasone; Lactose; Particle Size; Powders; Respiratory Aerosols and Droplets; Salmeterol Xinafoate; Spectrum Analysis | 2023 |